WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: Supporting developing country production capacity through technology transfer

Vaccine

Volumn 29, Issue SUPPL. 1, 2011, Pages

  Friede, Martin ^a   Palkonyay, Laszlo ^a   Alfonso, Claudia ^a   Pervikov, Yuri ^a   Torelli, Guido ^a   Wood, David ^a   Kieny, Marie Paule ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Capacity building; Developing countries; Influenza; LAIV; Manufacturing; Pandemic; Technology transfer; Vaccine

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ARTICLE; BRAZIL; DEVELOPING COUNTRY; DRUG COST; DRUG INDUSTRY; EGYPT; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HUMAN; INDIA; INDONESIA; IRAN; MEXICO; PANDEMIC INFLUENZA; PRIORITY JOURNAL; ROMANIA; SEASONAL INFLUENZA; SERBIA; SOUTH KOREA; TECHNOLOGY; THAILAND; VACCINATION; VACCINE PRODUCTION; VIET NAM; WORLD HEALTH ORGANIZATION;

ANIMALS; BIRDS; DEVELOPING COUNTRIES; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PANDEMICS; TECHNOLOGY TRANSFER; TECHNOLOGY, PHARMACEUTICAL; WORLD HEALTH ORGANIZATION;

EID: 79959196090     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.079     Document Type: Article

References (10)

1. Development and evaluation of influenza pandemic vaccines: review of a WHO expert meeting, Geneva, 2-3 November 2005 (, accessed 15 January 2011). http://www.who.int/entity/vaccine_research/documents/Report%2520021105.pdf.
2. Kieny M.P., Costa A., Hombach J., Carrasco P., Pervikov Y., Salisbury D., et al. A global pandemic influenza vaccine action plan. Vaccine 2006, 24(40-41):6367-6370.
3. Collin N., de Radiguès X. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine 2009, 27:5184-5186.
4. A review of production technologies for influenza virus vaccines, and their suitability for deployment in developing countries for influenza pandemic preparedness. Geneva, World Health Organization, 2006 (, accessed 22 January 2011). http://www.who.int/vaccine_research/diseases/influenza/Flu_vacc_manuf_tech_report.pdf.
5. Mapping of intellectual property related to the production of pandemic influenza vaccines, 23 October 2007. Geneva, World Health Organization, 2007 (, accessed 22 January 2011). http://www.who.int/vaccine_research/diseases/influenza/Mapping_Intellectual_Property_Pandemic_Influenza_Vaccines.pdf.
6. Friede M., Serdobova I., Palkonyay L., Kieny M.P. Technology transfer hub for pandemic influenza vaccine. Vaccine 2009, 27(5):631-632.
7. Préaud JM. ARVAC project: the " Enabling Platform" model. World Health Organization Workshop on Technology Transfer. Geneva, 30 November to 1 December 2010 (, accessed 15 January 2011). http://www.who.int/phi/news/Presentation8.pdf.
8. Rudenko L., van den Bosch H., Kiseleva I., Mironov A., Naikhin A., Larionova N., Bushmenkov D. Live attenuated pandemic influenza vaccine: Clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries. Vaccine 2011, 29(S1):A40-A44.
9. Hendriks J., Holleman M., de Boer O., de Jong P., Luyties W. An international technology platform for influenza vaccines. Vaccine 2011, 29(S1):A8-A11.
10. Collin N., Dubois P.M. The Vaccine Formulation Laboratory: A platform for access to adjuvants. Vaccine 2011, 29(S1):A37-A39.